Literature DB >> 11222704

Virus-neutralizing monoclonal antibody expressed in milk of transgenic mice provides full protection against virus-induced encephalitis.

A F Kolb1, L Pewe, J Webster, S Perlman, C B Whitelaw, S G Siddell.   

Abstract

Neutralizing antibodies represent a major host defense mechanism against viral infections. In mammals, passive immunity is provided by neutralizing antibodies passed to the offspring via the placenta or the milk as immunoglobulin G and secreted immunoglobulin A. With the long-term goal of producing virus-resistant livestock, we have generated mice carrying transgenes that encode the light and heavy chains of an antibody that is able to neutralize the neurotropic JHM strain of murine hepatitis virus (MHV-JHM). MHV-JHM causes acute encephalitis and acute and chronic demyelination in susceptible strains of mice and rats. Transgene expression was targeted to the lactating mammary gland by using the ovine beta-lactoglobulin promoter. Milk from these transgenic mice contained up to 0.7 mg of recombinant antibody/ml. In vitro analysis of milk derived from different transgenic lines revealed a linear correlation between antibody expression and virus-neutralizing activity, indicating that the recombinant antibody is the major determinant of MHV-JHM neutralization in murine milk. Offspring of transgenic and control mice were challenged with a lethal dose of MHV-JHM. Litters suckling nontransgenic dams succumbed to fatal encephalitis, whereas litters suckling transgenic dams were fully protected against challenge, irrespective of whether they were transgenic. This demonstrates that a single neutralizing antibody expressed in the milk of transgenic mice is sufficient to completely protect suckling offspring against MHV-JHM-induced encephalitis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11222704      PMCID: PMC115905          DOI: 10.1128/JVI.75.6.2803-2809.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  Maternal antibodies block malaria.

Authors:  M Fried; F Nosten; A Brockman; B J Brabin; P E Duffy
Journal:  Nature       Date:  1998-10-29       Impact factor: 49.962

2.  Transgenic mice secreting coronavirus neutralizing antibodies into the milk.

Authors:  I Sola; J Castilla; B Pintado; J M Sánchez-Morgado; C B Whitelaw; A J Clark; L Enjuanes
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

3.  Antitransferrin receptor antibody-RNase fusion protein expressed in the mammary gland of transgenic mice.

Authors:  D L Newton; D Pollock; P DiTullio; Y Echelard; M Harvey; B Wilburn; J Williams; H R Hoogenboom; J C Raus; H M Meade; S M Rybak
Journal:  J Immunol Methods       Date:  1999-12-10       Impact factor: 2.303

4.  Protective immunity against murine hepatitis virus (MHV) induced by intranasal or subcutaneous administration of hybrids of tobacco mosaic virus that carries an MHV epitope.

Authors:  M Koo; M Bendahmane; G A Lettieri; A D Paoletti; T E Lane; J H Fitchen; M J Buchmeier; R N Beachy
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

5.  Hyperimmune bovine colostrum specific for recombinant Cryptosporidium parvum antigen confers partial protection against cryptosporidiosis in immunosuppressed adult mice.

Authors:  M C Jenkins; C O'Brien; J Trout; A Guidry; R Fayer
Journal:  Vaccine       Date:  1999-05-14       Impact factor: 3.641

6.  Human milk lactoferrin inactivates two putative colonization factors expressed by Haemophilus influenzae.

Authors:  J Qiu; D R Hendrixson; E N Baker; T F Murphy; J W St Geme; A G Plaut
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

7.  Brain tumors induced with Rous sarcoma virus, Schmidt-Ruppin strain. I. Induction of brain tumors in adult mice with Rous chicken sarcoma cells.

Authors:  T Kumanishi
Journal:  Jpn J Exp Med       Date:  1967-10

8.  Isolation and recombinant expression of an MHV-JHM neutralising monoclonal antibody.

Authors:  A F Kolb; M Lechermaier; A Heister; A Toksoy; S G Siddell
Journal:  Adv Exp Med Biol       Date:  1998       Impact factor: 2.622

9.  Engineering passive immunity in transgenic mice secreting virus-neutralizing antibodies in milk.

Authors:  J Castilla; B Pintado; I Sola; J M Sánchez-Morgado; L Enjuanes
Journal:  Nat Biotechnol       Date:  1998-04       Impact factor: 54.908

Review 10.  Transgenic milk as a method for the production of recombinant antibodies.

Authors:  D P Pollock; J P Kutzko; E Birck-Wilson; J L Williams; Y Echelard; H M Meade
Journal:  J Immunol Methods       Date:  1999-12-10       Impact factor: 2.303

View more
  17 in total

1.  Control of central nervous system viral persistence by neutralizing antibody.

Authors:  Chandran Ramakrishna; Cornelia C Bergmann; Roscoe Atkinson; Stephen A Stohlman
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

Review 2.  Mammary gland immunity and mastitis susceptibility.

Authors:  Lorraine M Sordillo; Katie L Streicher
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-04       Impact factor: 2.673

3.  Maternally derived recombinant human anti-hantavirus monoclonal antibodies are transferred to mouse offspring during lactation and neutralize virus in vitro.

Authors:  Shuyang Yu; Mifang Liang; Baoliang Fan; Hongtao Xu; Chuan Li; Quanfu Zhang; Dexin Li; Bo Tang; Shijie Li; Yunping Dai; Meili Wang; Min Zheng; Bingxue Yan; Qinghong Zhu; Ning Li
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

4.  The recombinant chimeric antibody chHAb18 against hepatocellular carcinoma can be produced in milk of transgenic mice.

Authors:  Jingjing Wei; Xiangmin Yang; Min Zheng; Meili Wang; Yunping Dai; Zhinan Chen; Ning Li
Journal:  Transgenic Res       Date:  2010-06-12       Impact factor: 2.788

5.  Development of transgenic mice expressing calcitonin as a beta-lactoglobulin fusion protein in mammary gland.

Authors:  Ahmadreza Niavarani; Somaye Dehghanizadeh; Sirous Zeinali; Mohsen Karimi; Marc Magliano; Minoo Rassoulzadegan
Journal:  Transgenic Res       Date:  2005-10       Impact factor: 2.788

6.  Transgenic mice expressing a soluble form of porcine nectin-1/herpesvirus entry mediator C as a model for pseudorabies-resistant livestock.

Authors:  Etsuro Ono; Keiko Amagai; Satoshi Taharaguchi; Yukiko Tomioka; Saori Yoshino; Yuki Watanabe; Pierre Cherel; Louis-Marie Houdebine; Micheline Adam; Marc Eloit; Manabu Inobe; Toshimitsu Uede
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-08       Impact factor: 11.205

7.  Mouse hepatitis virus infection of the CNS: a model for defense, disease, and repair.

Authors:  Chris S Schaumburg; Katherine S Held; Thomas E Lane
Journal:  Front Biosci       Date:  2008-05-01

8.  High level expression of a functional human/mouse chimeric anti-CD20 monoclonal antibody in milk of transgenic mice.

Authors:  Bo Tang; Shanshan Yu; Min Zheng; Fangrong Ding; Rui Zhao; Jianmin Zhao; Yunping Dai; Ning Li
Journal:  Transgenic Res       Date:  2008-01-09       Impact factor: 2.788

9.  West Nile virus meningitis in a chronic immunosuppressed patient with rheumatoid arthritis.

Authors:  John A Batsis; Michael P Phy
Journal:  Clin Rheumatol       Date:  2005-04-23       Impact factor: 3.650

10.  CD8+ T Cells Responding to the Middle East Respiratory Syndrome Coronavirus Nucleocapsid Protein Delivered by Vaccinia Virus MVA in Mice.

Authors:  Svenja Veit; Sylvia Jany; Robert Fux; Gerd Sutter; Asisa Volz
Journal:  Viruses       Date:  2018-12-16       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.